No woman deserves to die of cervical cancer. Cervical cancer is a preventable public health problem that can be eliminated
through vaccination, screening and early treatment.
Cervical cancer is a completely preventable public health problem. Yet one young woman dies every two minutes in this world, leaving behind her young children to poverty and economic despair.
The majority of HPV-related cancers are preventable.
(Above are approximate nos.) Source: Best Practice & Research Clinical Obstetrics and Gynaecology. 2018: Plummer et al. Lancet Glob Health. 2016
To eliminate HPV-related cancers, starting with cervical cancer
Working with our global partners we:
Raise awareness about HPV-related cancers
Improve cervical cancer screening rates
Facilitate early treatment
In Rwanda, 75% of women with cervical cancer don’t survive. The “One Egg-A-Day” initiative provides essential nutrition to those in treatment. Help us support these women—donate today.
GIAHC is proud to have been a part of the launch of the Mysore Consortium Against Cervical Cancer (MCACC) during the week of the centennial celebration of Mysore Medical College (Dr. Krishnan’s alma mater).
GIAHC is deeply honored to be a part of the “Quad Cancer Moonshot team,” collaborating with our partners to take bold action against #cervicalcancer in the Asia Pacific region. Together, we are committed to eliminating this disease for a healthier future.
Women in Asia are diagnosed with cervical cancer at a disproportionately higher rate than the global average. Despite early diagnosis leading to more effective treatment, many factors in the region prevent women from receiving the care that they need, and the consequences are severe, affecting not only women as individuals, but society at large.
It has been a great honor to be a part of President Biden’s Cancer Moonshot delegation to India and to participate in the US-India Cancer Dialogue Initiative.
GIAHC is excited to announce its partnership with CAPED India. Together, they will raise awareness about HPV vaccination among parents in India and develop an educational series for healthcare providers on cervical cancer screening and early treatment.
GIAHC is excited to announce its partnership with CAPED India. Together, they will raise awareness about HPV vaccination among parents in India and develop an educational series for healthcare providers on cervical cancer screening and early treatment.
The report details a campaign by GIAHC and PHRII on March 4th, International HPV Awareness Day, to boost HPV awareness in Mysuru. It focused on educating young adults and healthcare trainees, supporting WHO’s cervical cancer elimination efforts, and planning future prevention strategies.
On March 4th, GIAHC and PHRII in Mysore, India, will begin a week of HPV awareness events, highlighting the importance of vaccination and screening, culminating in a screening camp on International Women’s Day, March 8th.
GIAHC, in collaboration with Vaccine Ambassadors, is spearheading a fundraising initiative to donate 6,000 HPV vaccine doses to Suriname.
Global Initiative Against HPV and Cervical Cancer (GIAHC) has announced a partnership with The Global HPV Consortium, spearheaded by the Sabin Vaccine Institute. This collaboration aims to intensify efforts to combat Human Papilloma Virus (HPV) infections and eradicate cervical cancer as a major public health issue.
Discover how the HPV vaccine can be a key player in preventing multiple cancers and explore actionable steps Congress can take to boost vaccination rates nationwide.
The 2024 Us vs HPV webinar series will take place from January 22-26. The webinars are intended for health care providers, parents, patients, community leaders, women’s health advocates, students, young leaders and the general public. People of all genders can benefit from these talks. A live panel discussion will be hosted at the end of each session to answer audience questions.
It’s Up to Us: Race to End HPV-Related Cancers Starting with Cervical Cancer. Organized by Global Initiative Against HPV (GIAHC) and Cervical Cancer partners.
HPW is devoted to disseminate messages on HPV with clinical relevance and make them widely available in open access and e-formats.